Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
InDevR, a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has […]
TTP Introduces Cellular Origins, a TTP Company Focussed on Delivering Scalable Manufacture of Cell and Gene Therapies
TTP, a leading independent technology and product development company, has today announced the launch of […]
Optibrium Appoints Steve Yemm as Chief Commercial Officer
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the […]
FDA Accepts GMP Plasmid DMF of OBiO Technology
OBiO Technology, a gene and cell therapy-focused contract research organization (CRO) and contract development and […]
Avacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Study
Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces […]
Amylyx Pharmaceuticals Announces Exclusive AMX0035 Distribution Agreement with Israel-Based Neopharm
Amylyx Pharmaceuticals today announced it has entered into an exclusive license and distribution agreement with […]
Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs
Immunovia, the diagnostics company that has launched the world’s first blood test dedicated to the […]
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer
Full-Life Technologies has announced the appointments of Steffen Heeger, MD, PhD, as Chief Medical Officer […]
OncoK9 Liquid Biopsy Test Can Enhance Cancer Monitoring in Dogs, New Results Show
PetDx, The Liquid Biopsy Company for Pets™, has released a white paper demonstrating that OncoK9®, […]
Eagle Genomics Disclose Funding from OMRON Ventures to Drive Sustainability Innovation in Microbiome R&D
Today, Eagle Genomics, the pioneering TechBio platform business applying network science to biology, disclosed additional […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more